Asthmatic bronchial smooth muscle (BSM) is characterized by structural remodeling associated with mast cell infiltration displaying features of chronic degranulation. Mast cell-derived tryptase can activate protease activated receptor type-2 (PAR-2) of BSM cells. The aims of the present study were (i) to evaluate the expression of PAR-2 in both asthmatic and non asthmatic BSM cells and, (ii) to analyze the effect of prolonged stimulation of PAR-2 in asthmatic BSM cells on cell signaling and proliferation. BSM cells were obtained from both 33 control subjects and 22 asthmatic patients. PAR-2 expression was assessed by flow cytometry, western blot and quantitative RT-PCR. Calcium response, transduction pathways and proliferation were evaluated before and following PAR-2 stimulation by SLIGKV-NH2 or trypsin for 1 to 3 days. Asthmatic BSM cells expressed higher basal levels of functional PAR-2 compared to controls in terms of mRNA, protein expression and calcium response. When PAR-2 expression was increased by means of lentivirus in control BSM cells to a level similar to that of asthmatic cells, PAR-2-induced calcium response was then similar in both types of cell. However, repeated PAR-2 stimulations increased the proliferation of asthmatic BSM cells but not that of control BSM cells even following lentiviral over-expression of PAR-2. Such an increased proliferation was related to an increased phosphorylation of ERK in asthmatic BSM cells. In conclusion, we have demonstrated that asthmatic BSM cells express increased baseline levels of functional PAR-2. This higher basal level of PAR-2 accounts for the increased calcium response to PAR-2 stimulation, whereas the increased proliferation to repeated PAR-2 stimulation is related to increased ERK phosphorylation.
References
[1]
Bara I, Ozier A, Tunon de Lara JM, Marthan R, Berger P (2010) Pathophysiology of bronchial smooth muscle remodelling in asthma. Eur Respir J 36: 1174–1184. doi: 10.1183/09031936.00019810
[2]
Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, et al. (2002) Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 346: 1699–1705. doi: 10.1056/nejmoa012705
[3]
Berger P, Girodet PO, Begueret H, Ousova O, Perng DW, et al. (2003) Tryptase-stimulated human airway smooth muscle cells induce cytokine synthesis and mast cell chemotaxis. Faseb J 17: 2139–2141. doi: 10.1096/fj.03-0041fje
[4]
Brightling CE, Ammit AJ, Kaur D, Black JL, Wardlaw AJ, et al. (2005) The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med 171: 1103–1108. doi: 10.1164/rccm.200409-1220oc
[5]
El-Shazly A, Berger P, Girodet PO, Ousova O, Fayon M, et al. (2006) Fraktalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma. J Immunol 176: 1860–1868. doi: 10.4049/jimmunol.176.3.1860
[6]
Yang W, Kaur D, Okayama Y, Ito A, Wardlaw AJ, et al. (2006) Human lung mast cells adhere to human airway smooth muscle, in part, via tumor suppressor in lung cancer-1. J Immunol 176: 1238–1243. doi: 10.4049/jimmunol.176.2.1238
[7]
Girodet PO, Ozier A, Trian T, Begueret H, Ousova O, et al. (2010) Mast cell adhesion to bronchial smooth muscle in asthma specifically depends on CD51 and CD44 variant 6. Allergy 65: 1004–1012. doi: 10.1111/j.1398-9995.2009.02308.x
[8]
Begueret H, Berger P, Vernejoux JM, Dubuisson L, Marthan R, et al. (2007) Inflammation of bronchial smooth muscle in allergic asthma. Thorax 62: 8–15. doi: 10.1136/thx.2006.062141
[9]
Walls AF, Jones DB, Williams JH, Church MK, Holgate ST (1990) Immunohistochemical identification of mast cells in formaldehyde-fixed tissue using monoclonal antibodies specific for tryptase. J Pathol 162: 119–126. doi: 10.1002/path.1711620204
[10]
Tran T, Stewart AG (2003) Protease-activated receptor (PAR)-independent growth and pro-inflammatory actions of thrombin on human cultured airway smooth muscle. Br J Pharmacol 138: 865–875. doi: 10.1038/sj.bjp.0705106
[11]
Berger P, Compton SJ, Molimard M, Walls AF, N'Guyen C, et al. (1999) Mast cell tryptase as a mediator of hyperresponsiveness in human isolated bronchi. Clin Exp Allergy 29: 804–812. doi: 10.1046/j.1365-2222.1999.00580.x
[12]
Berger P, Tunon-De-Lara JM, Savineau JP, Marthan R (2001) Selected contribution: tryptase-induced PAR-2-mediated Ca(2+) signaling in human airway smooth muscle cells. J Appl Physiol 91: 995–1003.
[13]
Trian T, Girodet PO, Ousova O, Marthan R, Tunon-de-Lara JM, et al. (2006) RNA interference decreases PAR-2 expression and function in human airway smooth muscle cells. Am J Respir Cell Mol Biol 34: 49–55. doi: 10.1165/rcmb.2005-0187oc
Ramos-Barbon D, Fraga-Iriso R, Brienza NS, Montero-Martinez C, Verea-Hernando H, et al. (2010) T Cells localize with proliferating smooth muscle alpha-actin+ cell compartments in asthma. Am J Respir Crit Care Med 182: 317–324. doi: 10.1164/rccm.200905-0745oc
[16]
Kaminska M, Foley S, Maghni K, Storness-Bliss C, Coxson H, et al. (2009) Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction. J Allergy Clin Immunol 124: 45–51. doi: 10.1016/j.jaci.2009.03.049
[17]
Berger P, Perng DW, Thabrew H, Compton SJ, Cairns JA, et al. (2001) Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells. J Appl Physiol 91: 1372–1379.
[18]
Bara I, Ozier A, Girodet PO, Carvalho G, Cattiaux J, et al. (2012) Role of YKL-40 in bronchial smooth muscle remodeling in asthma. Am J Respir Crit Care Med 185: 715–722. doi: 10.1164/rccm.201105-0915oc
[19]
Johnson PR, Black JL, Carlin S, Ge Q, Underwood PA (2000) The production of extracellular matrix proteins by human passively sensitized airway smooth-muscle cells in culture: the effect of beclomethasone. Am J Respir Crit Care Med 162: 2145–2151. doi: 10.1164/ajrccm.162.6.9909111
[20]
Roth M, Johnson PR, Borger P, Bihl MP, Rudiger JJ, et al. (2004) Dysfunctional interaction of C/EBPalpha and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells. N Engl J Med 351: 560–574. doi: 10.1056/nejmoa021660
[21]
Knight DA, Lim S, Scaffidi AK, Roche N, Chung KF, et al. (2001) Protease-activated receptors in human airways: upregulation of PAR-2 in respiratory epithelium from patients with asthma. J Allergy Clin Immunol 108: 797–803. doi: 10.1067/mai.2001.119025
[22]
GINA Global Strategy for Asthma Management and Prevention, Global Inititive for Asthma (GINA). (2012). Available from : http://www.ginasthma.org. Accessed 2013 Aug 3
[23]
Carvalho G, Poalas K, Demian C, Hatchi E, Vazquez A, et al. (2011) Participation of the cell polarity protein PALS1 to T-cell receptor-mediated NF-kappaB activation. PLoS One 6. doi: 10.1371/journal.pone.0018159
[24]
Chambers LS, Black JL, Poronnik P, Johnson PR (2001) Functional effects of protease-activated receptor-2 stimulation on human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 281: L1369–1378.
[25]
Hamilton JR, Chow JM, Cocks TM (1999) Protease-activated receptor-2 turnover stimulated independently of receptor activation in porcine coronary endothelial cells. Br J Pharmacol 127: 617–622. doi: 10.1038/sj.bjp.0702583
[26]
Nystedt S, Ramakrishnan V, Sundelin J (1996) The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor. J Biol Chem 271: 14910–14915. doi: 10.1074/jbc.271.25.14910
[27]
Mahn K, Hirst SJ, Ying S, Holt MR, Lavender P, et al. (2009) Diminished sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) expression contributes to airway remodelling in bronchial asthma. Proc Natl Acad Sci U S A 106: 10775–10780. doi: 10.1073/pnas.0902295106
